Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Journal of Medicinal Chemistry|July 9, 2023
Recent advances in Fragment-based strategies against tuberculosisBaptiste Villemagne, Léo Faion, Salia Tangara, et al.
European Journal of Medicinal Chemistry|March 17, 2012
Tuberculosis: the drug development pipeline at a glanceBaptiste Villemagne, Céline Crauste, Marion Flipo, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 7, 2013
Structural and docking studies of potent ethionamide boostersNatalie J Tatum, Baptiste Villemagne, Nicolas Willand, et al.
International Journal of Pharmaceutics|May 20, 2017
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugsGiuseppina Salzano, Jitendra Wankar, Stefano Ottani, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Rapid and Efficient Access to Novel Bio-Inspired 3-Dimensional Tricyclic SpiroLactams as Privileged Structures via Meyers' LactamizationSalia Tangara, Léo Faïon, Catherine Piveteau, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
Pyrrolomycins Are Potent Natural ProtonophoresKatherine Valderrama, Elizabeth Pradel, Alexander M Firsov, et al.
Analytical Biochemistry|February 25, 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligandsCéline Crauste, Nicolas Willand, Baptiste Villemagne, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|December 17, 2018
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthRAbdalkarim Tanina, Alexandre Wohlkönig, Sameh H Soror, et al.
Pageof 2